Trevi Therapeutics Inc
Biotechnology
Healthcare
TRVI
101 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
5.78
52 week high
7.06
high
5.78
52 week low
2.49
previous Close
5.77
P/E ratio
market cap
382 M
div yield
0
net incoming
-13.24 M
-7.21 %
net profit margin
-1324200000.00 %
0.00 %
operating incoming
-14.09 M
-6.00 %
net change in cash
3.09 M
464.27 %
cash on hand
16.05 M
23.83 %
top